Kemp Dolliver
Stock Analyst at Brookline Capital
(2.02)
# 1,519
Out of 4,479 analysts
16
Total ratings
50%
Success rate
-8.66%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DARE Daré Bioscience | Upgrades: Buy | $3 | $3.79 | -20.84% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $7.41 | +323.75% | 1 | Jan 25, 2024 | |
| CYCC Cyclacel Pharmaceuticals | Downgrades: Hold | n/a | $1.62 | - | 1 | Dec 19, 2023 | |
| ONCT Oncternal Therapeutics | Upgrades: Buy | $40 | $7.02 | +470.21% | 2 | Dec 4, 2023 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $80.00 | +25.00% | 1 | Nov 30, 2023 | |
| EYEN Eyenovia | Initiates: Buy | $8 | $0.68 | +1,078.38% | 1 | Oct 17, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $4.39 | +1,198.41% | 2 | Oct 12, 2023 | |
| PROC Procaps Group | Downgrades: Hold | $4.5 | $2.61 | +72.41% | 1 | Sep 6, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $1.84 | +1,258.70% | 1 | May 18, 2023 | |
| ECOR electroCore | Initiates: Buy | $19 | $6.43 | +191.60% | 1 | Jan 13, 2023 | |
| SCYX SCYNEXIS | Assumes: Buy | $8 | $1.95 | +310.26% | 1 | Oct 21, 2022 | |
| VRCA Verrica Pharmaceuticals | Initiates: Buy | $20 | $7.95 | +151.57% | 1 | Mar 10, 2022 | |
| ICCM IceCure Medical | Initiates: Buy | $5.65 | $0.74 | +664.86% | 1 | Feb 2, 2022 |
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $3
Current: $3.79
Upside: -20.84%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $7.41
Upside: +323.75%
Cyclacel Pharmaceuticals
Dec 19, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.62
Upside: -
Oncternal Therapeutics
Dec 4, 2023
Upgrades: Buy
Price Target: $40
Current: $7.02
Upside: +470.21%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $80.00
Upside: +25.00%
Eyenovia
Oct 17, 2023
Initiates: Buy
Price Target: $8
Current: $0.68
Upside: +1,078.38%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $4.39
Upside: +1,198.41%
Procaps Group
Sep 6, 2023
Downgrades: Hold
Price Target: $4.5
Current: $2.61
Upside: +72.41%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $1.84
Upside: +1,258.70%
electroCore
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $6.43
Upside: +191.60%
SCYNEXIS
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $1.95
Upside: +310.26%
Verrica Pharmaceuticals
Mar 10, 2022
Initiates: Buy
Price Target: $20
Current: $7.95
Upside: +151.57%
IceCure Medical
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.74
Upside: +664.86%